Review
Copyright ©The Author(s) 2022.
World J Gastroenterol. May 21, 2022; 28(19): 2057-2075
Published online May 21, 2022. doi: 10.3748/wjg.v28.i19.2057
Table 1 Incidences of aberrant right and common hepatic artery during pancreaticoduodenectomy in the English literature (> 50 cases)
Ref.
Year
Total, n
Male, n
PDAC, n
a/rRHA, n (%)
aRHA1, n (%)
rRHA1, n (%)
rCHA, n (%)
Detecting methods
Wang et al[7]202157631714972 (12.5)27 (4.7)28 (4.9)20 (3.5)CTA
Mansour et al[5]2021202NANA37 (18.3)3 (1.5)29 (14.4)0Surgical finding
Giani et al[25]2021270NANA66 (24.4)3 (1.1)39 (14.4)10 (3.7)CT
Zhang et al[3]20202181226136 (16.5)13 (6.0)11 (5.1)7 (3.2)CTA
Crocetti et al[34]201929717829744 (14.8)NANANACTA, surgical finding
Alexakis et al[4]2019232NANA32 (13.8)19 (8.2)13 (5.6)1 (0.4)Surgical finding
Balzan et al[9]201920093NA26 (13.0)2 (1.0)17 (8.5)7 (3.5)CT
Kim et al[33]201673352415 (20.5)4 (5.5)11 (15.1)NACT, surgical finding
Nguyen et al[31]2015142765716 (11.3)014 (9.9)9 (6.3)CT, surgical finding
Yang et al[32]201545824229154 (11.8)15 (3.3)29 (6.3)10 (2.2)CT, DSA, surgical finding
Rammohan et al[17]20142251673142 (18.7)10 (4.4)31 (13.8)1 (0.4)CT, surgical finding
Kim et al[26]201428915828938 (13.1)3 (1.0)31 (10.7)2 (0.7)Surgical finding
Sulpice et al[30]2013213NANA29 (13.6)NANANACT, surgical finding
Turrini et al[29]2010471NA47147 (10.0)2 (0.4)44 (9.3)NACT, surgical finding
Lee et al[28]200910373015 (14.6)012 (11.7)0MRA, surgical finding
Total396914611670540 (14.4)101 (2.9)309 (8.9)67 (2.3)
Table 2 Surgical outcomes of pancreaticoduodenectomy in patients with and without aberrant hepatic artery (> 50 cases)
Ref.
Total, n
AHA, n
Morbidity, n (%)
POPF, n (%)
PPH, n (%)
DGE, n (%)
Reoperation, n (%)
Mortality, n (%)
AHA
n-AHA
AHA
n-AHA
AHA
n-AHA
AHA
n-AHA
AHA
n-AHA
AHA
n-AHA
OPD
Rammohan et al[17]2254326 (60.5)111 (61.0)2 (4.7)9 (4.9)1 (2.3)4 (2.1)23 (53.4)98 (53.8)NANA1 (2.3)3 (1.7)
Kim et al[26]24937192 (24.3)882 (41.5)1 (2.7)12 (5.6)1 (2.7)16 (7.6)4 (10.8)16 (7.6)NANA01 (0.5)
Sulpice3 et al[30]8429114 (48.3)32 (58.2)3 (10.3)9 (16.4)4 (13.8)9 (16.4)10 (34.5)24 (43.6)NANA3 (10.3)3 (5.5)
Eshuis et al[53]75814380 (55.9)303 (49.3)18 (12.6)87 (14.1)11 (7.7)44 (7.2)48 (33.6)193 (31.4)10 (7.0)68 (11.0)2 (1.4)13 (2.1)
Mansour3 et al[5]824122 (53.7)27 (65.9)8 (19.5)12 (29.3)4 (9.8)3 (7.3)6 (14.6)7 (17.1)001 (2.4)0
Crocetti et al[34]29744132 (72.7)185 (73.1)5 (11.3)27 (10.7)2 (4.5)12 (4.7)5 (11.4)37 (14.6)3 (6.8)28 (11.7)7 (15.9)33 (13.0)
Alexakis3 et al[4]105354 (11.4)19 (27.1)2 (5.7)9 (12.9)02 (2.9)1 (2.9)1 (1.4)1 (2.9)5 (7.1)2 (5.7)4 (5.7)
LPD
Wang et al[7]576127NANA21 (16.5)68 (15.1)11 (9.0)37 (8.2)3 (2.5)9 (2.0)4 (3.1)24 (5.3)4 (3.1)12 (2.7)
Giani et al[25]721415 (35.7)34 (58.6)2 (14.3)10 (17.2)2 (14.3)10 (17.2)2 (14.3)14 (24.1)NANA04 (6.9)
Zhang et al[3]2185422 (40.7)70 (42.7)5 (2.3)21 (9.6)5 (2.3)15 (6.9)NANANANA3 (3.7)7 (4.3)
RPD
Nguyen et al[31]1423019 (63.3)74 (66.0)4 (13.3)9 (8.1)NANA3 (10.0)26 (23.2)NANA2 (6.7)3 (2.7)
Kim et al[33]731515 (33.3)29 (50.0)2 (13.3)5 (8.6)1 (6.7)5 (8.6)NANA2 (13.3)4 (6.9)02 (3.4)
Table 3 Oncological outcomes of pancreaticoduodenectomy in patients with and without aberrant hepatic artery (> 50 cases)
AuthorTotal, nAHA, nR0 resection, n (%)
Median OS (mo)
Median HLN, n
AHA
n-AHA
AHA
n-AHA
AHA
n-AHA
OPD
Crocetti et al[34]29744142 (95.5)220 (87.0)3025NANA
Alexakis2 et al[4]1053529 (82.9)56 (80.0)NANANANA
Rubio-Manzanares-Dorado et al[62]1511111 (100.0)116 (82.9)NANA1012
Rammohan et al[17]2254340 (93.1)169 (92.9)NANA1212
Kim et al[26]24937133 (89.2)178 (84.0)17231717
Sulpice2 et al[30]8429125 (86.2)49 (89.1)21.823.61626
Turrini et al[29]623125 (80.7)26 (83.9)23171113
Lee et al[28]10315112 (80.0)66 (75.0)29.828.7NANA
LPD
Wang et al[7]576127NANA28321514
Giani et al[25]7214111 (84.6)50 (86.2)NANA223173
Zhang et al[3]2185454 (100.0)163 (99.4)NANA18.5918.26
RPD
Nguyen et al[31]1152725 (92.6)77 (87.5)NANA22.317.5